Hong Kong start-up lowers cost of early autism detection using whole genome sequencing

A diagnostics firm in Hong Kong wants to make it affordable to identify autism risks in young children, as recent medical advances significantly lower the cost of whole genome sequencing-based disease detection.


  • No comments yet.
  • Add a comment